# Reports
## Outbreak updates
### Global
#### [WHO Disease Outbreak News](https://github.com/midas-network/2019-ncov/tree/master/cases/who/disease_outbreak_news) ([metadata](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/collection_metadata.csv))
* 14 January, 2020 - [World Health Organization (WHO). (2020). Novel Coronavirus – Thailand (ex-China). Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Thailand%20(ex-China)_20200114.pdf)
* 16 January, 2020 - [World Health Organization (WHO). (2020). Emergencies preparedness, response Novel Coronavirus – China. Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Japan%20(ex-China)_20200116.pdf)
* 17 January, 2020 - [World Health Organization (WHO). (2020). Emergencies preparedness, response Novel Coronavirus – China. Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Japan%20(ex-China)_20200117.pdf)

* 21 January, 2020 - [World Health Organization (WHO). (2020). Emergencies preparedness, response Novel Coronavirus – China. Geneva.](https://github.com/midas-network/2019-ncov/blob/master/cases/who/disease_outbreak_news/WHO%20_%20Novel%20Coronavirus%20%E2%80%93%20Republic%20of%20Korea%20(ex-China)_20200121.pdf)


## Modelling reports
### China
17 January, 2020 - [Imai, N., Dorigatti, I., Cori, A., Riley, S., & Ferguson, N. M. (2020). Report 1: Estimating the potential total number of novel Coronavirus (2019-nCoV) cases in Wuhan City, China. London.](https://github.com/midas-network/2019-ncov/blob/master/Documents/reports/model_reports/china/2019-nCoV-outbreak-report-17-01-2020.pdf) 


# Pre-prints & Peer-Reviewed Papers
## Estimating Epidemiological Parameters
19 January 2020 - [Chen T, Rui J, Wang Q, Zhao Z, Cui J-A, Yin L. A mathematical model for simulating the transmission of Wuhan novel Coronavirus. bioRxiv. 2020:2020.01.19.911669.](https://doi.org/10.1101/2020.01.19.911669)

24 January 2020 - [Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019-nCoV. bioRxiv. 2020:2020.01.23.917351.](https://doi.org/10.1101/2020.01.23.917351)

25 January 2020 - [Thompson RN. 2019-20 Wuhan coronavirus outbreak: Intense surveillance is vital for preventing sustained transmission in new locations. bioRxiv. 2020:2020.01.24.919159.](https://doi.org/10.1101/2020.01.24.919159)

26 January 2020 - [Liu T, Hu J, Kang M, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020:2020.01.25.919787.](https://doi.org/10.1101/2020.01.25.919787)

28 January 2020 - [Linton NM, Kobayashi T, Yang Y, et al. Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data. medRxiv. 2020:2020.01.26.20018754.](https://doi.org/10.1101/2020.01.26.20018754)

28 January 2020 - [Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv. 2020:2020.01.23.20018549.](https://doi.org/10.1101/2020.01.23.20018549)

29 January 2020 - [Cao Z, Zhang Q, Lu X, et al. Estimating the effective reproduction number of the 2019-nCoV in China. medRxiv. 2020:2020.01.27.20018952.](https://www.medrxiv.org/content/10.1101/2020.01.27.20018952v1)

30 January 2020 - [Backer JA, Klinkenberg D, Wallinga J. The incubation period of 2019-nCoV infections among travellers from Wuhan, China. medRxiv. 2020:2020.01.27.20018986.](https://doi.org/10.1101/2020.01.27.20018986)

30 January 2020 - [Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020:S1201-9712(20)30053-9.](https://doi.org/10.1016/j.ijid.2020.01.050)

31 January 2020 - [Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet (London, England). 2020:S0140-6736(20)30260-9.](https://doi.org/10.1016/S0140-6736(20)30260-9)

31 January 2020 - [Zhou T, Liu Q, Yang Z, et al. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. arXiv Prepr arXiv200110530. January 2020. http://arxiv.org/abs/2001.10530.](http://arxiv.org/abs/2001.10530)

2 February 2020 - [Jung S, Akhmetzhanov AR, Hayashi K, et al. Real time estimation of the risk of death from novel coronavirus (2019-nCoV) infection: Inference using exported cases. medRxiv. 2020:2020.01.29.20019547.](https://doi.org/10.1101/2020.01.29.20019547)

2 February 2020 - [Kucharski AJ, Russell TW, Diamond C, Funk S, Eggo RM. Early dynamics of transmission and control of 2019-nCoV: a mathematical modelling study. medRxiv. 2020:2020.01.31.20019901.](https://doi.org/10.1101/2020.01.31.20019901)

3 February 2020 - [Shaman J, Galanti M. Direct Measurement of Rates of Asymptomatic Infection and Clinical Care-Seeking for Seasonal Coronavirus. medRxiv. 2020:2020.01.30.20019612.](https://doi.org/10.1101/2020.01.30.20019612)

4 February 2020 - [Chen J. Pathogenicity and Transmissibility of 2019-nCoV-A Quick Overview and Comparison with Other Emerging Viruses. Microbes Infect. February 2020:S1286-4579(20)30026-5.](https://www.sciencedirect.com/science/article/pii/S1286457920300265)

4 February 2020 - [Lauer SA, Grantz KH, Bi Q, et al. The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application. medRxiv. 2020:2020.02.02.20020016.](https://doi.org/10.1101/2020.02.02.20020016)

4 February 2020 - [Nishiura H, Kobayashi T, Yang Y, et al. The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights. J Clin Med. 2020;9(2):E419](https://doi.org/10.3390/jcm9020419)

5 February 2020 - [Hermanowicz SW. Forecasting the Wuhan coronavirus (2019-nCoV) epidemics using a simple (simplistic) model. medRxiv. 2020:2020.02.04.20020461.](https://doi.org/10.1101/2020.02.04.20020461)

5 February 2020 - [Spencer J, Shutt DP, Moser SK, et al. Epidemiological parameter review and comparative dynamics of influenza, respiratory syncytial virus, rhinovirus, human coronavirus, and adenovirus. medRxiv. 2020:2020.02.04.20020404.](https://doi.org/10.1101/2020.02.04.20020404)

5 February 2020 - [Tuite AR, Fisman DN. Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic. Ann Intern Med. 2020.](https://doi.org/10.7326/m20-0358)

7 February 2020 - [Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher RA. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020;150:w20203-w20203.](https://doi.org/10.4414/smw.2020.20203)

7 February 2020 - [Muniz-Rodriguez K, Chowell G, Cheung C-H, et al. Epidemic doubling time of the 2019 novel coronavirus outbreak by province in mainland China. medRxiv. 2020:2020.02.05.20020750.](https://doi.org/10.1101/2020.02.05.20020750)

7 February 2020 - [Park SW, Champredon D, Earn DJD, et al. Reconciling early-outbreak preliminary estimates of the basic reproductive number and its uncertainty: a new framework and applications to the novel coronavirus (2019-nCoV) outbreak. medRxiv. 2020:2020.01.30.20019877.](https://doi.org/10.1101/2020.01.30.20019877)

## Spread and Possibility of Containment

## Scenario Projections & Forecasting

## Impact of Interventions
18 January 2020 - [Cheng VCC, Wong S-C, To KKW, Ho PL, Yuen K-Y. Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China. J Hosp Infect. 2020:S0195-6701(20)30034-7.](https://doi.org/10.1016/j.jhin.2020.01.010)

28 January 2020 - [Lodge EK, Schatz AM, Drake JM. Protective Population Behavior Change in Outbreaks of Emerging Infectious Disease. bioRxiv. 2020:2020.01.27.921536.](https://doi.org/10.1101/2020.01.27.921536)

28 January 2020 - [Shao P, Shan Y. Beware of asymptomatic transmission: Study on 2019-nCoV prevention and control measures based on extended SEIR model. bioRxiv. 2020:2020.01.28.923169.](https://doi.org/10.1101/2020.01.28.923169)

01 February 2020 - [Errett NA, Sauer LM, Rutkow L. An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure. J Emerg Manag (Weston, Mass). 2020;18(1):7-14.](https://doi.org/10.5055/jem.2020.0446)

02 February 2020 - [Quilty B, Clifford S, Flasche S, Eggo RM. Effectiveness of airport screening at detecting travellers infected with 2019-nCoV. medRxiv. 2020:2020.01.31.20019265.](https://doi.org/10.1101/2020.01.31.20019265)

02 February 2020 - [Tian H, Li Y, Liu Y, et al. Early evaluation of the Wuhan City travel restrictions in response to the 2019 novel coronavirus outbreak. medRxiv. 2020:2020.01.30.20019844.](https://doi.org/10.1101/2020.01.30.20019844)

03 February 2020 - [Gostic K, Gomez ACR, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of traveller screening to prevent international spread of 2019 novel coronavirus (2019-nCoV). medRxiv. 2020:2020.01.28.20019224.](https://doi.org/10.1101/2020.01.28.20019224)

5 February 2020 - [Ai S, Zhu G, Tian F, et al. Population movement, city closure and spatial transmission of the 2019-nCoV infection in China. medRxiv. 2020:2020.02.04.20020339.](https://doi.org/10.1101/2020.02.04.20020339)

07 February 2020 - [Muniz-Rodriguez K, Chowell G, Cheung C-H, et al. Epidemic doubling time of the 2019 novel coronavirus outbreak by province in mainland China. medRxiv. 2020:2020.02.05.20020750.](https://doi.org/10.1101/2020.02.05.20020750)

## Virus Evolution

## Clinical and Community Trials

## Observational Studies
16 January 2020 - [Lu H, Stratton CW, Tang Y-W. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle. J Med Virol. 2020:10.1002/jmv.25678.](https://doi.org/10.1002/jmv.25678)

21 January 2020 -[Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):135.](https://doi.org/10.3390/v12020135)

24 January 2020 - [Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (London, England). 2020:S0140-6736(20)30154-9.](https://doi.org/10.1016/S0140-6736(20)30154-9)

24 January 2020 - [Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019-nCoV. bioRxiv. 2020:2020.01.23.917351.](https://doi.org/10.1101/2020.01.23.917351)

24 January 2020 - [Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet (London, England). January 2020:S0140-6736(20)30185-9.](https://doi.org/10.1016/S0140-6736(20)30185-9)

24 January 2020 - [Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan , China. Lancet. 2020;6736(20):1-10.](https://doi.org/10.1016/S0140-6736(20)30183-5)

28 January 2020 - [Linton NM, Kobayashi T, Yang Y, et al. Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data. medRxiv. 2020:2020.01.26.20018754.](https://doi.org/10.1101/2020.01.26.20018754)

28 January 2020 - [Lodge EK, Schatz AM, Drake JM. Protective Population Behavior Change in Outbreaks of Emerging Infectious Disease. bioRxiv. 2020:2020.01.27.921536.](https://doi.org/10.1101/2020.01.27.921536)

29 January - [Strzelecki A. Infodemiological Study Using Google Trends on Coronavirus Epidemic in Wuhan, China. arXiv. January 2020. http://arxiv.org/abs/2001.11021.](http://arxiv.org/abs/2001.11021)

30 January 2020 - [Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020:S0140-6736(20)30211-7.](https://doi.org/10.1016/S0140-6736(20)30211-7)

30 January 2020 - [Zhao S, Zhuang Z, Ran J, et al. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report. Travel Med Infect Dis. January 2020:101568.](https://doi.org/10.1016/j.tmaid.2020.101568)

2 February 2020 - [Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020:S1286-4579(20)30025-3.](https://doi.org/10.1016/j.micinf.2020.01.003)

2 February 2020 - [Zhang R, Liu H, Li F, et al. Transmission and epidemiological characteristics of Novel Coronavirus (2019-nCoV)-Infected Pneumonia(NCIP):preliminary evidence obtained in comparison with 2003-SARS. medRxiv. 2020:2020.01.30.20019836.](https://doi.org/10.1101/2020.01.30.20019836)

3 February 2020 - [Jung S, Kinoshita R, Thompson RN, et al. Epidemiological identification of a novel infectious disease in real time: Analysis of the atypical pneumonia outbreak in Wuhan, China, 2019-20. medRxiv. 2020:2020.01.26.20018887.](https://doi.org/10.1101/2020.01.26.20018887)

3 February - 2020 [Kim JY, Choe PG, Oh Y, et al. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures. J Korean Med Sci. 2020;35(5):e61-e61.](https://doi.org/10.3346/jkms.2020.35.e61)

3 February 2020 - [Tian HY. _2019-nCoV: new challenges from coronavirus_. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(0):E001.](https://doi.org/10.3760/cma.j.issn.0253-9624.2020.0001)

4 February 2020 [Cai JH, Wang XS, Ge YL, et al. _First case of 2019 novel coronavirus infection in children in Shanghai_. Zhonghua Er Ke Za Zhi. 2020;58(0):E002.](https://doi.org/10.3760/cma.j.issn.0578-1310.2020.0002)

4 February 2020 - [Chen J. Pathogenicity and Transmissibility of 2019-nCoV-A Quick Overview and Comparison with Other Emerging Viruses. Microbes Infect. February 2020:S1286-4579(20)30026-5.](https://www.sciencedirect.com/science/article/pii/S1286457920300265)

4 February 2020 - [Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020:200230.](https://doi.org/10.1148/radiol.2020200230)

4 February 2020 - [Kanne JP. Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist. Radiology. 2020:200241.](https://doi.org/10.1148/radiol.2020200241)

4 February 2020 - [Lauer SA, Grantz KH, Bi Q, et al. The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application. medRxiv. 2020:2020.02.02.20020016.](https://doi.org/10.1101/2020.02.02.20020016)

4 February - [Sun K, Chen J, Viboud C. Early epidemiological analysis of the 2019-nCoV outbreak based on a crowdsourced data. medRxiv. 2020:2020.01.31.20019935.](https://doi.org/10.1101/2020.01.31.20019935)

5 February 2020 - [Habibzadeh P, Stoneman EK. The Novel Coronavirus: A Bird’s Eye View. Int J Occup Env Med. 2020;11(2):65-71.](https://doi.org/10.15171/ijoem.2020.1921)

6 February 2020 - [Kang M, Wu J, Ma W, et al. Human-to-human transmission of 2019-novel coronavirus (2019-nCoV). medRxiv. 2020:2020.02.03.20019141.](https://doi.org/10.1101/2020.02.03.20019141)

6 February - [Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019‐nCoV) in Japan: mental health consequences and target populations. Psychiatry Clin Neurosci. February 2020:pcn.12988.](https://doi.org/10.1111/pcn.12988)

6 February 2020 - [Song F, Shi N, Shan F, et al. Emerging Coronavirus 2019-nCoV Pneumonia. Radiology. 2020:200274.](https://doi.org/10.1148/radiol.2020200274)

7 February 2020 - [Chang D, Lin M, Wei L, et al. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. JAMA. February 2020:10.1001/jama.2020.1623.](https://doi.org/10.1001/jama.2020.1623)

7 February 2020 - [Fang Y, Zhang H, Xu Y, Xie J, Pang P, Ji W. CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. February 2020:200280.](https://doi.org/10.1148/radiol.2020200280)

7 February 2020 - [Shi H, Han X, Zheng C. Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China. Radiology. February 2020:200269.](https://doi.org/10.1148/radiol.2020200269)

7 February 2020 - [Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. February 2020:10.1001/jama.2020.1585.](https://doi.org/10.1001/jama.2020.1585)

## Microbiological and Immunological studies
22 January 2020 - [Dong N, Yang X, Ye L, et al. Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. bioRxiv. 2020:2020.01.20.913368.](https://doi.org/10.1101/2020.01.20.913368)

22 January 2020 - [Letko M, Munster V. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV. bioRxiv. 2020:2020.01.22.915660.](https://doi.org/10.1101/2020.01.22.915660)

23 January 2020 - Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020:10.1038/s41586-020-2012-2017. [metadata]
- [Nature](https://doi.org/10.1038/s41586-020-2012-7)
- [bioRxiv](https://doi.org/10.1101/2020.01.22.914952)

25 January 2020 - [Li G, Fan Y, Lai Y, et al. Coronavirus Infections and Immune Responses. J Med Virol. 2020:10.1002/jmv.25685.](https://doi.org/10.1002/jmv.25685)

26 January 2020 - [Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020:2020.01.26.919985.](https://doi.org/10.1101/2020.01.26.919985)

28 January 2020 - [Tian X, Li C, Huang A, et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. bioRxiv. 2020:2020.01.28.923011.](https://doi.org/10.1101/2020.01.28.923011)

28 January 2020 - [Xu Z, Peng C, Shi Y, et al. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv. 2020:2020.01.27.921627.](https://doi.org/10.1101/2020.01.27.921627)

29 January 2020 - [Liu X, Wang X-J. Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines. bioRxiv. 2020:2020.01.29.924100.](https://doi.org/10.1101/2020.01.29.924100)

30 January 2020 - [Li Y, Zhang J, Wang N, et al. Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening. bioRxiv. 2020:2020.01.28.922922.](https://doi.org/10.1101/2020.01.28.922922)

30 January - [Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England). 2020:S0140-6736(20)30251-8.](https://doi.org/10.1016/S0140-6736(20)30251-8)

30 January 2020 - [Pillaiyar T, Meenakshisundaram S, Manickam M. Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov Today. January 2020:S1359-6446(20)30041-6.](https://doi.org/10.1016/j.drudis.2020.01.015)

31 January 2020 - [Chu DKW, Pan Y, Cheng SMS, et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. January 2020:hvaa029.](https://doi.org/10.1093/clinchem/hvaa029)

31 January 2020 - [Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020:2020.01.31.929042.](https://doi.org/10.1101/2020.01.31.929042)

31 January 2020 - [Jiang S, Du L, Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 2020;9(1):275-277.](https://doi.org/10.1080/22221751.2020.1723441)

31 January 2020 - [Ju J, Kumar S, Li X, Jockusch S, Russo JJ. Nucleotide Analogues as Inhibitors of Viral Polymerases. bioRxiv. 2020:2020.01.30.927574.](https://doi.org/10.1101/2020.01.30.927574)

31 January 2020 - [Rut W, Żmudziński M, Snipas SJ, Bekes M, Huang TT, Drag M. Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes. bioRxiv. 2020:2020.01.30.926881.](https://doi.org/10.1101/2020.01.30.926881)

31 January 2020 - [Zhang H, Kang Z, Gong H, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. 2020:2020.01.30.927806.](https://doi.org/10.1101/2020.01.30.927806)

2 February 2020 - [Beal J, Mitchell T, Wyschogrod D, Manthey J, Clore A. Highly Distinguished Amino Acid Sequences of 2019-nCoV (Wuhan Coronavirus). bioRxiv. 2020:2020.01.31.929497.](https://doi.org/10.1101/2020.01.31.929497)

2 February 2020 - [Beck BR, Shin B, Choi Y, Park S, Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model. bioRxiv. 2020:2020.01.31.929547.](https://doi.org/10.1101/2020.01.31.929547)

3 February 2020 - [Lei C, Fu W, Qian K, et al. Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig. bioRxiv. 2020:2020.02.01.929976.](https://doi.org/10.1101/2020.02.01.929976)

3 February 2020 [Lin S, Shen R, Guo X. Molecular Modeling Evaluation of the Binding Abilities of Ritonavir and Lopinavir to Wuhan Pneumonia Coronavirus Proteases. bioRxiv. 2020:2020.01.31.929695.](https://doi.org/10.1101/2020.01.31.929695)

4 February 2020 - [Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies. bioRxiv. 2020:2020.02.03.933226.](https://doi.org/10.1101/2020.02.03.933226)

4 February 2020 - [Chai X, Hu L, Zhang Y, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv. 2020:2020.02.03.931766.](https://doi.org/10.1101/2020.02.03.931766)

4 February 2020 - [Huang Q, Herrmann A. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020:2020.02.01.930537.](https://doi.org/10.1101/2020.02.01.930537)

4 February 2020 - [Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R, Conti P. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J Biol Regul Homeost Agents. 2019;34(1):10.23812/20-Editorial-Kritas.](https://doi.org/10.23812/20-Editorial-Kritas)

4 February 2020 - [Nguyen DD, Gao K, Wang R, Wei G. Machine intelligence design of 2019-nCoV drugs. bioRxiv. 2020:2020.01.30.927889.](https://doi.org/10.1101/2020.01.30.927889)

4 February 2020 - [Ramaiah A, Arumugaswami V. Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development. bioRxiv. 2020:2020.01.29.925867.](https://doi.org/10.1101/2020.01.29.925867)

4 February 2020 - [Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. February 2020.](https://doi.org/10.1038/s41422-020-0282-0)

5 February 2020 - [Baruah V, Bose S. Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol. 2020.](https://doi.org/10.1002/jmv.25698)

5 February 2020 - [He X, Zhang L, Ran Q, et al. Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV. medRxiv. 2020:2020.02.03.20020206.](https://doi.org/10.1101/2020.02.03.20020206)

5 February 2020 - [Li H, Wang YM, Xu JY, Cao B. _Potential antiviral therapeutics for 2019 Novel Coronavirus_. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E002.](https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0002)

5 February 2020 - [Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based Drug Repurposing for Human Coronavirus. medRxiv. 2020:2020.02.03.20020263.](https://doi.org/10.1101/2020.02.03.20020263)

7 February 2020 - [Dennis Lo YM, Chiu RWK. Racing towards the development of diagnostics for a novel coronavirus (2019-nCoV). Clin Chem. February 2020:hvaa038.](https://doi.org/10.1093/clinchem/hvaa038)

7 February 2020 - [Wang J, Zhao S, Liu M, et al. ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism. medRxiv. 2020:2020.02.05.20020545.](https://doi.org/10.1101/2020.02.05.20020545)

7 February 2020 - [Xiao S-Y, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review]. J Med Virol. February 2020:10.1002/jmv.25702.](https://doi.org/10.1002/jmv.25702)

## Potential Therapeutics
28 January 2020 - [Xu Z, Peng C, Shi Y, et al. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv. 2020:2020.01.27.921627.](https://doi.org/10.1101/2020.01.27.921627)

29 January 2020 - [Liu X, Wang X-J. Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines. bioRxiv. 2020:2020.01.29.924100.](https://doi.org/10.1101/2020.01.29.924100)

30 January 2020 - [Li Y, Zhang J, Wang N, et al. Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening. bioRxiv. 2020:2020.01.28.922922.](https://doi.org/10.1101/2020.01.28.922922)

30 January 2020 - [Pillaiyar T, Meenakshisundaram S, Manickam M. Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov Today. January 2020:S1359-6446(20)30041-6.](https://doi.org/10.1016/j.drudis.2020.01.015)

1 February 2020 - [Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020:S1286-4579(20)30025-3.](https://doi.org/10.1016/j.micinf.2020.01.003)

2 February 2020 - [Beck BR, Shin B, Choi Y, Park S, Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model. bioRxiv. 2020:2020.01.31.929547.](https://doi.org/10.1101/2020.01.31.929547)

3 February 2020 - [Lin S, Shen R, Guo X. Molecular Modeling Evaluation of the Binding Abilities of Ritonavir and Lopinavir to Wuhan Pneumonia Coronavirus Proteases. bioRxiv. 2020:2020.01.31.929695.](https://doi.org/10.1101/2020.01.31.929695)

4 February 2020 - [Nguyen DD, Gao K, Wang R, Wei G. Machine intelligence design of 2019-nCoV drugs. bioRxiv. 2020:2020.01.30.927889.](https://doi.org/10.1101/2020.01.30.927889)

4 February 2020 - [Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. February 2020.](https://doi.org/10.1038/s41422-020-0282-0)

5 February 2020 - [Li H, Wang YM, Xu JY, Cao B. _Potential antiviral therapeutics for 2019 Novel Coronavirus_. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E002.](https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0002)

5 February 2020 - [Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based Drug Repurposing for Human Coronavirus. medRxiv. 2020:2020.02.03.20020263.](https://doi.org/10.1101/2020.02.03.20020263)

## Other studies


# Guidelines
## WHO
## China
## United States


